Classification and Differential Diagnosis of Diabetic Nephropathy

Table 4

Literature review of NDRD in China.

Author	Year of publication	References	Number of patients	Pathological diagnosis			Statistical analysis of NDRD (alone and coexistent with DN)
				DN	NDRD	DN plus NDRD
Mak et al.	1997	[35]	51	67	16	17	IgAN (59%), HTN (24%)
Wong et al.	2002	[36]	68	35	46	19	IgAN (29.5%), HTN (20.4%), MN (18.2%), MCD (9%)
Cao et al.	2007	[37]	120	85.8	—	14.2	IgAN (41.2%), MN (17.6%), HTN (11.7%), TIN (11.7%), RA (5.9%), FSGS (5.9%), micropolyarteritis (5.9%)
Zhou et al.	2008	[38]	110	54.5	—	45.5	IgAN (34%), MN (22%), MPGN (14%), HBV-associated GN (8%), MCD (4%), HTN (4%), MPGN (4%), CrGN (2%)
Lin et al.	2009	[39]	50	48	22	30	MN (19.23%), IgAN (11.54%), MCD (3.85%), HTN (3.85%), ATN (3.85%), CIN (7.69%)
Mou et al.	2010	[40]	69	47.8	52.2	—	FSGS (37.7%), IgAN (15.9%), MCD (15.9%), MN (8.7%)
Bi et al.	2011	[41]	220	54.5	—	45.5	IgAN (34%), MN (22%), MPGN (14%), HBV-associated GN (8%), MCD (4%), HTN (4%), MPGN (4%), CrGN (2%)
Zhang et al.	2011	[42]	130	73.9	26.1	—	IgAN (16.9%), MN (6.15%)
Zhuo et al.	2013	[43]	216	6.5	82.9	10.7	17–35 years (group I): IgAN (29%), MN (11.8%), FSGS (8.8%), MPGN (8.8%), APGN (5.9%), CrGN (5.9%); 36–59 years (group II): IgAN (34.7%), MN (15%), FSGS (1.4%), MPGN (6.1%), APGN (0.7%), CrGN (1.4%); 60 years (group III): IgAN (2.9%), FSGS (2.9%), MN (25.7%), CrGN (8.6%), MPGN (11.4%), RA (5.7%)
Peng and Wang	2013	[44]	61	52.5	—	47.5	IgAN (31%), MN (17.2%), MPGN (13.8%), HTN (13.8%), FSGS (10.3%), MCD (6.9%), APGN (3.5%)
Wang	2015	[45]	56	57.1		42.9	IgAN (33.3%), MN (25.0%), MPGN (20.8%), HTN (8.3%), FSGS (4.2%), MCD (4.2%)

Note. IgAN, primary IgA nephropathy; HTN, hypertensive nephrosclerosis; MN, membranous nephropathy; MCD, minimal change disease; TIN, tubulointerstitial nephritis; RA, renal amyloidosis; MPGN, mesangial proliferative glomerulonephritis; CrGN, crescentic glomerulonephritis; ATN, acute tubular necrosis; CIN, chronic interstitial nephritis; FSGS, focal segmental glomerular sclerosis.